The FDA approved a label update for 2 versions of the Depo-Provera birth control injection to include the risk for meningioma.

The CDC no longer recommends universal hepatitis B vaccination at birth, instead excluding babies born to mothers negative for hepatitis B.

Early results from a phase 2 clinical trial show that denifanstat for 12 weeks improved lesion counts in patients with acne vulgaris.

Concerns about the state of the US health care system, including that it may be in crisis, were among the highest recorded levels.

Telitacicept in combination with standard therapy was effective for the treatment of systemic lupus erythematosus through 52 weeks.

The FDA warned major retailers of possible legal action after they sold recalled infant formula amid an infant botulism outbreak.

In a combined network meta-analysis, infliximab and adalimumab had the greatest risk for serious infection in patients with plaque psoriasis.

Hair growth nutraceuticals significantly improve hair fiber diameter and decrease breakage across various patient populations.

The FDA began a safety review of RSV monoclonal antibody treatments for infants despite the products' safety records.

Pediatric COVID vaccination reduced the risk of emergency room visits, especially in children aged 4 years and younger.

Tanning bed use was associated with higher risk for melanoma, melanoma on sites with low cumulative sun exposure, and multiple melanomas.

South Carolina health officials placed 254 people in quarantine and confirmed 114 cases of measles in the state.